Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager What are protein therapeutics / monoclonal antibodies? Protein therapeutics, specifically monoclonal antibodies (mAbs), have emerged as the most marketed biologic drug Continue Reading
Biosimilars, Generic Drugs, and the Pharmaceutical Industry
Author: Chad Eichman, PhD – BioPharmaceutical Global Marketing Manager How Biosimilars are Affecting the Pharmaceutical Industry Honey Nut Cheerios™ or Honey Nut Tasteeos®? Glad® Trash Bags or Walmart’s Great Value™ Continue Reading
Is Your LC Column for Biologics Analysis, Truly Bio-Inert?
Let’s talk about column priming and how to address this common concern Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager With the emerging trend of biotherapeutics in the pharmaceutical industry, Continue Reading
Large vs Small Organic Molecules in Biopharmaceuticals
Biopharmaceuticals have emerged as the next-gen of therapeutic (large and small) molecules in the pharmaceutical industry Guest Author: Chad Eichman, Ph.D., Biopharmaceutical Industry Manager The pharmaceutical industry has a long-standing Continue Reading